Rising Treasury Yields Dent Biotech Stocks
Investors are turning cautious on biotechnology stocks as a rapid rise in Treasury yields dents the appeal for shares of companies viewed as risky all-or-nothing bets on breakthrough medical treatments.
Original · Bloomberg AI summary of public reporting
Why: Rising yields pressure growth stocks
Loading market data…
Recent signals
No matching events
Prices since publication
At publication → Currentpara:10Y— → ——
TLT81.05 → 81.05+0.0%
XBI152.21 → 151.77−0.3%